StockData
Dermata Therapeutics, Inc. logo

Dermata Therapeutics, Inc. (DRMA) shareholders

DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.57−0.03 (-4.75%)

Close on Nov 17, 2026Market cap $2.29MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
3.0%
0M of 4M shares
Institutional holders
13
7 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
1 buys · 1 sales
Net bought $1.26K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
1,065,0769.99%13G (passive) amendmentMar 31, 2025
Proehl Gerald T694,68717.30%13D (active) amendmentFeb 19, 2026
Bigger Michael414,0648.36%13G (passive)Sep 30, 2026
Kyri K. Van Hoose384,3529.00%13D (active)May 27, 2026
Intracoastal Capital LLC
Joint filing with Mitchell P. Kopin (5.50%), Daniel B. Asher (5.50%)
147,0595.50%13G (passive)Dec 24, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of DRMAValueChange% of portfolio
Geode Capital Management, LLC20,2030.50%$26.06K−28,1310.00%
Welch & Forbes LLC20,0000.50%$25.80K–0.00%
State Street Corp18,7470.47%$24.18KNew0.00%
UBS Group AG16,7960.42%$21.67K−18,8120.00%
Susquehanna International Group, Llp15,9890.40%$20.63KNew0.00%
XTX Topco Ltd14,7870.37%$19.08KNew0.00%
Advisory Alpha, LLC10,0000.25%$12.90KNew0.00%
Tower Research Capital LLC (TRC)3,8600.10%$4.98K+3,1440.00%
MCF Advisors LLC1,7320.04%$2.24K–0.00%
Barclays PLC2700.01%$348New0.00%
SBI Securities Co., Ltd.1010.00%$130–0.00%
Highline Wealth Partners LLC260.00%$34New0.00%
Morgan Stanley20.00%$3New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026130M3.0%7 / 12 / 10M0M
Q1 202670M2.6%3 / 13 / 220M3M
Q4 2025274M94.1%10 / 104 / 33M0M
Q3 2025201M29.6%3 / 152 / 101M0M
Q2 2025270M10.3%10 / 95 / 40M0M
Q1 2025220M8.7%4 / 48 / 80M0M
Q4 2024260M8.0%8 / 73 / 80M0M
Q3 2024260M2.4%5 / 64 / 60M0M
Q2 2024270M2.4%9 / 180 / 50M0M
Q1 2024230M0.1%8 / 51 / 100M0M
Q4 2023250M0.1%12 / 40 / 20M0M
Q3 2023150M0.0%2 / 13 / 40M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

2 funds held DRMA in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of DRMAValue% of fundAs of
Fidelity Extended Market Index Fund41,3211.03%$53.72K0.00%May 31, 2026
Fidelity Series Total Market Index Fund1,1060.03%$1.44K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Gerald T. ProehlPRESIDENT, CHAIRMAN, CEO, Director, 10% owner372,6159.26%Aug 18, 2026
Hoose Kyri K. VanSVP, CFO232,4635.78%Aug 18, 2026
Munera Maria E. Bedoya-ToroSVP, Regulatory Affairs1,0460.03%Mar 17, 2026
Christopher J. NardoSenior VP, CDO27,5600.69%Jan 6, 2026
Kathleen D. ScottDirector10.00%Jun 16, 2026
Mary FisherDirector196,9464.90%Jan 6, 2026
Andrew Seth SandlerDirector24,1840.60%Jan 6, 2026
David F. HaleDirector81,4692.03%Jan 6, 2026
Steven J. MentoDirector––Jan 6, 2026
Wendell WierengaDirector62,3981.55%Jan 6, 2026
Brittany BradrickDirector23,4430.58%Jan 6, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Hoose Kyri K. Van
SVP, CFO
Aug 16, 2026Award+102,040––232,463
Gerald T. Proehl
PRESIDENT, CHAIRMAN, CEO, Director, 10% owner
Aug 16, 2026Award+170,068––292,631
Kathleen D. Scott
Director
Jun 16, 2026Sale−11$1.19$130
Munera Maria E. Bedoya-Toro
SVP, Regulatory Affairs
Feb 17, 2026Buy+1,000$1.27$1.27K1,012
Gerald T. Proehl
PRESIDENT, CHAIRMAN, CEO, Director, 10% owner
Dec 23, 2025Award+490,196––490,255
Gerald T. Proehl
PRESIDENT, CHAIRMAN, CEO, Director, 10% owner
Dec 23, 2025Award+122,549––122,563
Hoose Kyri K. Van
SVP, CFO
Dec 23, 2025Award+122,549––130,423
David F. Hale
Director
Jan 23, 2025Award+78,741––80,957
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Jan 21, 2025Award+787,402––799,508
Hoose Kyri K. Van
SVP, CFO
Jan 21, 2025Award+78,741––78,741
Mary Fisher
Director
Jan 21, 2025Award+196,851––196,946
Kathleen D. Scott
Director
Oct 6, 2022Award+11,359––27,145
Mary Fisher
Director
Oct 6, 2022Award+9,810––23,443
Brittany Bradrick
Director
Oct 6, 2022Award+9,810––23,443
Andrew Seth Sandler
Director
Oct 6, 2022Award+10,120––24,184
David F. Hale
Director
Oct 6, 2022Award+30,155––75,720
Wendell Wierenga
Director
Oct 6, 2022Award+20,654––62,398
Kathleen D. Scott
Director
Jul 7, 2022Award+9,960––15,786
Wendell Wierenga
Director
Jul 7, 2022Award+18,110––41,744
Mary Fisher
Director
Jul 7, 2022Award+8,602––13,633
Andrew Seth Sandler
Director
Jul 7, 2022Award+8,874––14,064
Brittany Bradrick
Director
Jul 7, 2022Award+8,602––13,633
David F. Hale
Director
Jul 7, 2022Award+26,441––45,565
David F. Hale
Director
Apr 7, 2022Award+15,466––19,124
Mary Fisher
Director
Apr 7, 2022Award+5,031––5,031
Brittany Bradrick
Director
Apr 7, 2022Award+5,031––5,031
Kathleen D. Scott
Director
Apr 7, 2022Award+5,826––5,826
Andrew Seth Sandler
Director
Apr 7, 2022Award+5,190––5,190
Wendell Wierenga
Director
Apr 7, 2022Award+10,593––15,471
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Nov 23, 2021Buy+20,000$2.40$48.00K59,512
Investment Ventures LLC Proehl
10% owner
Aug 17, 2021Conversion+181,585––1,572,000
Investment Ventures LLC Proehl
10% owner
Aug 17, 2021Conversion+1,247,904––2,819,904
Investment Ventures LLC Proehl
10% owner
Aug 17, 2021Conversion+85,640––2,905,544
Investment Ventures LLC Proehl
10% owner
Aug 17, 2021Conversion+111,951––1,390,415
Investment Ventures LLC Proehl
10% owner
Aug 17, 2021Conversion+361,147––1,278,464
Wendell Wierenga
Director
Aug 17, 2021Conversion+8,163––13,041
Munera Maria E. Bedoya-Toro
Senior Vice President
Aug 17, 2021Conversion+13,658––84,143
Munera Maria E. Bedoya-Toro
Senior Vice President
Aug 17, 2021Conversion+17,421––70,485
Munera Maria E. Bedoya-Toro
Senior Vice President
Aug 17, 2021Conversion+4,878––53,064
Munera Maria E. Bedoya-Toro
Senior Vice President
Aug 17, 2021Conversion+19,512––48,186
Munera Maria E. Bedoya-Toro
Senior Vice President
Aug 17, 2021Conversion+9,162––28,674
Christopher J. Nardo
Senior VP, Development
Aug 17, 2021Conversion+2,439––2,439
David F. Hale
Director, 10% owner
Aug 17, 2021Conversion+20,000––331,606
David F. Hale
Director, 10% owner
Aug 17, 2021Conversion+27,103––532,925
David F. Hale
Director, 10% owner
Aug 17, 2021Conversion+174,216––505,822
David F. Hale
Director, 10% owner
Aug 17, 2021Buy+35,714––35,714
David F. Hale
Director, 10% owner
Aug 17, 2021Conversion+12,195––311,606
David F. Hale
Director, 10% owner
Aug 17, 2021Conversion+44,777––299,411
Thomas Insley
Chief Financial Officer
Aug 17, 2021Conversion+4,581––14,337
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+361,147––1,278,464
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+85,640––2,905,544
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+1,247,904––2,819,904
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+181,585––1,572,000
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+111,951––1,390,415
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Buy+142,857––152,857
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+35,767––35,767
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+8,928––8,928
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 17, 2021Conversion+17,857––17,857
Gerald T. Proehl
President, CEO and Chairman, Director, 10% owner
Aug 16, 2021Buy+10,000$4.96$49.60K10,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.16%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+9.0%
From 0M shares
Short volume, 20 days
39.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Dermata Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,963 shares on Aug 21, 2026 over the last 90 days.

See a number that looks wrong?